Joo Hwan No

1.7k total citations
41 papers, 927 citations indexed

About

Joo Hwan No is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Organic Chemistry. According to data from OpenAlex, Joo Hwan No has authored 41 papers receiving a total of 927 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Public Health, Environmental and Occupational Health, 17 papers in Epidemiology and 12 papers in Organic Chemistry. Recurrent topics in Joo Hwan No's work include Research on Leishmaniasis Studies (24 papers), Trypanosoma species research and implications (17 papers) and Synthesis and Biological Evaluation (9 papers). Joo Hwan No is often cited by papers focused on Research on Leishmaniasis Studies (24 papers), Trypanosoma species research and implications (17 papers) and Synthesis and Biological Evaluation (9 papers). Joo Hwan No collaborates with scholars based in South Korea, United States and Egypt. Joo Hwan No's co-authors include Eric Oldfield, Gyongseon Yang, Lúcio H. Freitas-Júnior, Yonghui Zhang, Andrew H.‐J. Wang, Yongcheng Song, Kyunghwa Baek, Wei Zhu, Nakyung Lee and Michael A. E. Hansen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and PLoS ONE.

In The Last Decade

Joo Hwan No

41 papers receiving 919 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joo Hwan No South Korea 17 411 354 234 196 169 41 927
Laura M. Sanz Spain 13 420 1.0× 769 2.2× 171 0.7× 254 1.3× 210 1.2× 21 1.3k
Sudaratana R. Krungkrai Thailand 21 592 1.4× 410 1.2× 183 0.8× 213 1.1× 224 1.3× 32 1.0k
M. Yogavel India 19 724 1.8× 286 0.8× 277 1.2× 108 0.6× 120 0.7× 66 1.3k
Prakash Saudagar India 19 337 0.8× 474 1.3× 296 1.3× 210 1.1× 128 0.8× 57 975
Victoria Barton United Kingdom 14 358 0.9× 738 2.1× 127 0.5× 316 1.6× 224 1.3× 16 1.2k
Alvin W. Hung Singapore 16 746 1.8× 315 0.9× 167 0.7× 434 2.2× 294 1.7× 27 1.5k
Bärbel Bergmann Germany 20 541 1.3× 752 2.1× 168 0.7× 120 0.6× 172 1.0× 31 1.3k
Pauline Machebœuf France 12 539 1.3× 169 0.5× 155 0.7× 74 0.4× 209 1.2× 16 1.1k
Francisca Lopes Portugal 19 374 0.9× 437 1.2× 157 0.7× 465 2.4× 216 1.3× 40 1.1k
Shailza Singh India 16 384 0.9× 243 0.7× 230 1.0× 124 0.6× 86 0.5× 99 879

Countries citing papers authored by Joo Hwan No

Since Specialization
Citations

This map shows the geographic impact of Joo Hwan No's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joo Hwan No with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joo Hwan No more than expected).

Fields of papers citing papers by Joo Hwan No

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joo Hwan No. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joo Hwan No. The network helps show where Joo Hwan No may publish in the future.

Co-authorship network of co-authors of Joo Hwan No

This figure shows the co-authorship network connecting the top 25 collaborators of Joo Hwan No. A scholar is included among the top collaborators of Joo Hwan No based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joo Hwan No. Joo Hwan No is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Hassan, Ahmed H.E., et al.. (2023). Rational repurposing, synthesis, in vitro and in silico studies of chromone-peptidyl hybrids as potential agents against Leishmania donovani. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2229071–2229071. 6 indexed citations
4.
Hassan, Ahmed H.E., et al.. (2023). Bestatin analogs-4-quinolinone hybrids as antileishmanial hits: Design, repurposing rational, synthesis, in vitro and in silico studies. European Journal of Medicinal Chemistry. 250. 115211–115211. 12 indexed citations
5.
Hassan, Ahmed H.E., et al.. (2023). Design, synthesis, and repurposing of O-aminoalkyl-sulfuretin analogs towards discovery of potential lead compounds as antileishmanial agents. European Journal of Medicinal Chemistry. 251. 115256–115256. 8 indexed citations
6.
Chu, Ki‐Back, et al.. (2023). Protective Humoral Immune Response Induced by Recombinant Virus-like Particle Vaccine Expressing Leishmania donovani Surface Antigen. ACS Infectious Diseases. 9(12). 2583–2592. 9 indexed citations
8.
Park, Kyu‐Ho, et al.. (2022). Discovery of novel Leishmania major trypanothione synthetase inhibitors by high-throughput screening. Biochemical and Biophysical Research Communications. 637. 308–313. 8 indexed citations
9.
Benítez, Diego, Jaime Franco, Rosario Durán, et al.. (2022). Drug-like molecules with anti-trypanothione synthetase activity identified by high throughput screening. Journal of Enzyme Inhibition and Medicinal Chemistry. 37(1). 912–929. 15 indexed citations
11.
Baek, Kyunghwa, et al.. (2020). Infectivity and Drug Susceptibility Profiling of Different Leishmania-Host Cell Combinations. Pathogens. 9(5). 393–393. 12 indexed citations
12.
Zahedifard, Farnaz, Joo Hwan No, Mona Salimi, et al.. (2019). Anti-leishmanial activity of Brevinin 2R and its Lauric acid conjugate type against L. major: In vitro mechanism of actions and in vivo treatment potentials. PLoS neglected tropical diseases. 13(2). e0007217–e0007217. 19 indexed citations
13.
Zahedifard, Farnaz, Joo Hwan No, Mona Salimi, et al.. (2019). Comparative study of different forms of Jellein antimicrobial peptide on Leishmania parasite. Experimental Parasitology. 209. 107823–107823. 26 indexed citations
14.
Yang, Gyongseon, Nakyung Lee, Jean‐Robert Ioset, & Joo Hwan No. (2016). Evaluation of Parameters Impacting Drug Susceptibility in Intracellular Trypanosoma cruzi Assay Protocols. SLAS DISCOVERY. 22(2). 125–134. 15 indexed citations
15.
Sun, Ya Nan, Joo Hwan No, Ga Young Lee, et al.. (2016). Phenolic Constituents of Medicinal Plants with Activity against Trypanosoma brucei. Molecules. 21(4). 480–480. 13 indexed citations
16.
Cruz, Deu John M., Andrea Cristine Koishi, Xiaolan Li, et al.. (2013). High Content Screening of a Kinase-Focused Library Reveals Compounds Broadly-Active against Dengue Viruses. PLoS neglected tropical diseases. 7(2). e2073–e2073. 21 indexed citations
17.
No, Joo Hwan, Yonghui Zhang, Yi-Liang Liu, et al.. (2012). Lipophilic analogs of zoledronate and risedronate inhibit Plasmodium geranylgeranyl diphosphate synthase (GGPPS) and exhibit potent antimalarial activity. Proceedings of the National Academy of Sciences. 109(11). 4058–4063. 54 indexed citations
18.
Song, Yongcheng, Fu‐Yang Lin, Joo Hwan No, et al.. (2009). Inhibition of Staphyloxanthin Virulence Factor Biosynthesis in Staphylococcus aureus: In Vitro, in Vivo, and Crystallographic Results. Journal of Medicinal Chemistry. 52(13). 3869–3880. 83 indexed citations
19.
Hudock, M.P., Yonghui Zhang, Rey‐Ting Guo, et al.. (2008). Inhibition of Geranylgeranyl Diphosphate Synthase by Bisphosphonates: A Crystallographic and Computational Investigation. Journal of Medicinal Chemistry. 51(18). 5594–5607. 67 indexed citations
20.
Wiesner, Jochen, René C. Röhrich, Ulrike Demmer, et al.. (2008). Structure of ( E )-4-Hydroxy-3-methyl-but-2-enyl Diphosphate Reductase, the Terminal Enzyme of the Non-Mevalonate Pathway. Journal of the American Chemical Society. 130(51). 17206–17207. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026